Abstract
MDL 101028, a novel biphenyl disulphonic acid urea co-polymer was designed and synthesised as a heparin mimetic. This low molecular weight polymer showed potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication in a number of host-cell/virus systems, including primary clinical isolates of the virus cultured in human peripheral blood mononuclear cells (PBMCs). When compared with the heterogeneous polysulphated molecules, heparin and dextran sulphate, this chemically defined compound showed equivalent antiviral activity with 50% inhibitory concentrations (IC50s) in the range 0.27-3.0 micrograms/ml in the host-cell/virus systems tested. MDL 101028 also inhibited the replication of HIV type 2 and the simian immunodeficiency virus (SIV), as well as HIV-1 variants resistant to reverse transcriptase inhibitors. Virus growth was blocked when exposure of T-lymphocytes to MDL 101028 was restricted to the virus absorption stage, or even in whole blood conditions. MDL 101028 did not irreversibly inactivate virions, and in contrast to heparin, did not inhibit the attachment of radiolabelled HIV-1 to CD4+ T-cells. MDL 101028 blocked HIV-induced cell-to-cell fusion and this activity appears to explain the mechanism of its ...Continue Reading
References
Jan 16, 1992·Biochimica Et Biophysica Acta·E MbembaL Gattegno
Jan 1, 1992·AIDS·M KootM Tersmette
Jun 1, 1991·AIDS·D L TaylorA S Tyms
Apr 1, 1990·Virology·D ScholsE De Clercq
Aug 1, 1991·The Journal of Experimental Medicine·Q J Sattentau, J P Moore
Dec 1, 1991·AIDS·M PetersB Ruf
Dec 1, 1991·Antimicrobial Agents and Chemotherapy·C FlexnerB G Petty
Jan 1, 1990·World Health Forum·W Dowdle
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E O FreedR Risser
Jun 6, 1986·Cell·B R StarcichR C Gallo
Jul 1, 1987·Antiviral Research·M ItoS Shigeta
Apr 29, 1988·Science·H MitsuyaS Broder
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M BabaE De Clercq
Aug 1, 1988·Journal of Virological Methods·R PauwelsE De Clercq
Feb 1, 1989·Annals of Internal Medicine·D I AbramsR Ueno
Jan 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A D Cardin, H J Weintraub
Sep 1, 1988·Antiviral Research·M BabaE De Clercq
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·M BabaE de Clercq
Jul 1, 1989·AIDS·E JurkiewiczG Hunsmann
Jun 1, 1989·Antiviral Research·H NakashimaN Yamamoto
Aug 5, 1988·Science·J D LifsonL E Eiden
Jun 5, 1987·Cell·B S SteinE G Engleman
Dec 18, 1987·Science·D H SmithD J Capon
Dec 1, 1985·Journal of Clinical Gastroenterology·S E Silvis
Citations
Apr 1, 1999·Biotechnology and Bioengineering·R O'KeeffeN K Slater
Apr 1, 1999·Biotechnology and Bioengineering·R S O'KeeffeN K Slater
Feb 2, 2010·Expert Reviews in Molecular Medicine·Allison H Bartlett, Pyong Woo Park
May 19, 2009·Pharmacology & Therapeutics·Marco RusnatiDavid Lembo
Nov 27, 2002·Antiviral Chemistry & Chemotherapy·Donald E BergstromErik De Clercq
Jun 28, 2017·Organic & Biomolecular Chemistry·Ryan J WeissYitzhak Tor
Nov 13, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chiara UrbinatiMarco Rusnati
Aug 6, 2020·Polymers·Natanel JarachSamuel Kenig